Ocumension Therapeutics (HKG:1477)

Hong Kong · Delayed Price · Currency is HKD

8.26

+0.10 (1.23%)

Apr 17, 2026, 3:35 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Discovering, Developing and Commercialising Ophthalmic Therapies	804.35M	417.31M	246.37M	158.96M	56.15M
Discovering, Developing and Commercialising Ophthalmic Therapies Growth	92.75%	69.38%	54.99%	183.11%	328.73%
Total	804.35M	417.31M	246.37M	158.96M	56.15M
Total Growth	92.75%	69.38%	54.99%	183.11%	328.73%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
People's Republic of China	804.35M	417.31M	246.37M	158.96M	56.15M
People's Republic of China Growth	92.75%	69.38%	54.99%	183.11%	328.73%
Total	804.35M	417.31M	246.37M	158.96M	56.15M
Total Growth	92.75%	69.38%	54.99%	183.11%	328.73%

Source: S&P Global Market Intelligence.